Viridian Biosciences

Viridian Biosciences is a biopharma incubator focused on bridging the gap between scientific discovery and product commercialization. The company identifies opportunities based on validated scientific findings and a keen understanding of unmet medical needs. By de-risking translational data, Viridian aims to build a portfolio of new companies dedicated to developing first-in-class or best-in-class therapeutic molecules. These initiatives target disease modification to alleviate the clinical and economic burdens associated with various health conditions, ultimately enhancing patients' lives. The initial leadership for these new ventures is provided by the Viridian team, ensuring that each program is grounded in robust scientific principles.